Clinical Trial Update: Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn's disease; study status terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Northwestern University | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-08-06